I wanted to join Betr Health to hopefully change the long line of gastrointestinal problems the men in my family have had. After 5 weeks, my stomach feels amazing! I sleep better, I have more energy in the day, and I’m down 20 lbs.
Joseph Jacquez
Member · 5 weeks in
−20 lbs
better sleep
gut healing
Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.Everyday, but Betr.
The downstream economics
What lower BMI does to the claims line.
BMI doesn’t just track health — it tracks cost. Two independent, peer-reviewed analyses (JAMA Network Open 2024, JOEM 2021) tie every BMI point to real dollars on the claims line. Betr’s verified median 8.1% BMI reduction sits squarely in the band where the savings are largest.
Betr verified outcome
−8.1%
Median BMI reduction across 5,634 participants BSGA 3rd-party verification, 2024
→
Projected annual savings · per member
$670–$1,427
employer-sponsored
$1,262+
Medicare
For a 5% weight loss. Range reflects baseline BMI of 30 to 45. Thorpe et al, JAMA Network Open, Dec 2024
Savings scale with weight loss.
Annual per-person reduction in healthcare spending by % weight loss, from a national instrumental-variables analysis of MEPS data (n=13,435 employer-sponsored; n=3,774 Medicare).
For members with these conditions, every single BMI point Betr removes is independently associated with this much lower annual spending — before counting the BMI reduction itself.
Diabetes (T2D)$752
Hypertension$367
Heart disease$285est.
Arthritis / back pain$210est.
Mental health disorders$170est.
Diabetes & hypertension figures: MEPS 2001–2015 IV analysis, JOEM 2021. Others: directional estimates from the same study, conditions for which savings were statistically significant.
Sources
Thorpe KE, Joski PJ, Yang Z.
Estimated Reduction in Health Care Spending Associated With Weight Loss in Adults
JAMA Network Open · December 2024
n=13,435 employer-sponsored · n=3,774 Medicare · IV analysis
Thorpe KE, Joski PJ, Yang Z.
Weight Loss-Associated Decreases in Medical Care Expenditures for Commercially Insured Patients With Chronic Conditions
Costs of obesity, obesity-related complications, and weight loss: A systematic literature review
J Managed Care Spec Pharm · 2025
Systematic review · meta-analysis of cost savings
Cawley J, Meyerhoefer C, Biener A, et al.
Savings in Medical Expenditures Associated with Reductions in BMI
PharmacoEconomics · 2015
MEPS 2000–2010 · IV analysis by diabetes status
If you’re considering a GLP-1, read this first
GLP-1 drugs vs. the original GLP.
We’re not anti-drug — we’re pro-biology. The Gut Loving Protocol is the original GLP: all natural, no injections, no regain when you stop, and a body that keeps doing the work for the rest of your life.
Who’s still in the game at week 12?
BCBSA / Blue Health Intelligence · n ≈ 170,000 commercial members
Betr GLP · 95% complete the full 8-week protocolGLP-1 medications · 64% drop off before week 12“Most people are unlikely to see lasting benefits.” — Razia Hashmi, MD, VP Clinical Affairs, BCBSA
And of those who finish — how much actually comes off?
% body change · trial endpoints
The drug headlines come from carefully controlled trial completers. Betr’s number comes from all 5,634 verified participants — completers and dropouts together. Read each bar with its sample, its timeline, and its asterisks.
Betr GLP
Gut Loving Protocol · all-natural
−8.1%
median across full 12-yr cohort · n = 5,634 · BSGA verified
Verified
Includes completers AND dropouts
Ozempic*
semaglutide 1.0 mg (T2D dose)
−6.2%
at 40 weeks · SUSTAIN 6 · trial completers *
Trial
Drug-required, ongoing
Wegovy*
semaglutide 2.4 mg (obesity dose)
−14.9%
at 68 weeks · STEP 1 · NEJM 2021 · n = 1,961 *
Trial
Trial completers only
Zepbound / Mounjaro*
tirzepatide 15 mg (highest dose)
−20.9%
at 72 weeks · SURMOUNT-1 · NEJM 2022 · n = 2,539 *
Trial
Trial completers only
−0%
−5%
−10%
−15%
−20%
−25%
The asterisk on the drug bars matters. Trial outcomes are reported on the ~36% of patients who stay on the drug past week 12. Apply BCBSA’s real-world attrition (64% drop by week 12, regain ~2/3 after stopping) and the average user-level weight loss in real life is a fraction of the trial endpoint. Betr’s 8.1% is unadjusted: it’s the median across everyone who enrolled.
What you actually want
Betr GLP
Gut Loving Protocol
GLP-1 drugs
Ozempic / Wegovy / Mounjaro
Time to first 5% body change
29 days median
BSGA verified
68 weeks for ~86% of users
STEP 1, NEJM 2021
Drop-off in first 4 weeks
~5%
Betr program data
40%+ quit
BCBSA / BHI 2024
Reach week 12
95% complete 8-week core
Betr program data
Only ~36% still on drug
BCBSA / BHI 2024
If you stop
Your body keeps the change
Gut, inflammation, identity
Regain ~2/3 of loss in 1 year
STEP 1 extension, 2022
Side effects
None — it's food
Nausea, GI common; pancreatitis risk
BCBS-KS 2-yr study
Monthly cost
HSA/FSA eligible · ~$1/meal
$617–$766 per 30-day supply
BHI / EBRI 2024
What you become
A different person
Many become Betr coaches
A subscriber
For life — to maintain
The ultimate transformation
Many of our members become Betr coaches.
The protocol doesn’t end at week 8. Members who’ve lived the change come back to certify, get matched with new members, and walk them through the same path. That’s not aftercare — that’s a career.
1 in 7
program graduates apply to coach
600+
active certified Betr coaches
100%
have lived the protocol themselves
Sources for drug data
BCBSA / Blue Health Intelligence (2024) “Most Americans Do Not Use Weight-Loss Drugs Long Enough to See Meaningful Weight-Loss.” n ≈ 170,000 commercial members · 2014–2024
Wilding JPH, et al. (NEJM, 2021) “Once-Weekly Semaglutide in Adults with Overweight or Obesity” (STEP 1). n = 1,961 · 68-week RCT
Wilding JPH, et al. (2022) “Weight regain and cardiometabolic effects after withdrawal of semaglutide” (STEP 1 extension). n = 327 · 120-week follow-up
BCBS Kansas (2025) 2-year real-world study of GLP-1 obesity therapy. n = 3,346 GLP-1 vs 8,343 controls
Members in their own words
Conditions Betr members are reversing
Members reversing diabetesMembers lowering blood pressureMembers healing GI conditionsMembers easing pain & inflammationMembers on mood, focus & calm
Lean in
Peek behind the curtain.
No enrollment. No quiz. No decision to be healthy today. Just a small step — and maybe the thought: maybe I've been chasing the wrong thing. That's the whole point. Betr starts the moment you lean in.